Synthesis and Biological Activity of Fluoroalkylamine Derivatives of Narcotic Analgesics

William G. Reifenrath, Edward B. Roche, Walid A. Al-Turk, Howard L. Johnson

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

N-Ethyl-, N-(2-fluoroethyl)-, N-(2, 2-difluoroethyl)-, and N-(2, 2, 2-trifluoroethyl)-substituted normeperidine (lb-e) and normetazocine (2b-e) derivatives were prepared. The analgesic activities of the compounds were determined in mice. Opiate receptor binding studies, in the presence and absence of sodium ion, were carried out. The antagonist activities of normetazocine derivatives were studied in monkeys. These were further examined in the isolated guinea pig ileum for relative agonist activity. The pKt values were measured; in vivo agonist activity was lost with weakly basic derivatives. For the normetazocine derivatives, opiate receptor binding data were consistent with guinea pig ileum agonist potency and mouse vas deferens antagonist potency but not with in vivo data. Opiate receptor binding was reduced for the less basic normetazocine derivatives. In the normeperidine series, there was no apparent direct relationship between pKt and opiate receptor binding. However, a relationship involving the hydrophobic character of the N-substituent is discussed. The N-(2-fluoroethyl) derivatives in both series were found to cause convulsions in rats at doses of 40-45 mg/kg ip. Elevated serum citrate levels were found in these rats, implicating in vivo oxidative deamination of the N-(fluoroalkyl) substituent to fluoroacetate.

Original languageEnglish (US)
Pages (from-to)985-990
Number of pages6
JournalJournal of Medicinal Chemistry
Volume23
Issue number9
DOIs
StatePublished - Jan 1 1980

Fingerprint

Narcotics
Opioid Receptors
Ileum
Guinea Pigs
Fluoroacetates
Deamination
Vas Deferens
Citric Acid
Haplorhini
Analgesics
Seizures
Sodium
Ions
normetazocine
Serum
normeperidine

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Synthesis and Biological Activity of Fluoroalkylamine Derivatives of Narcotic Analgesics. / Reifenrath, William G.; Roche, Edward B.; Al-Turk, Walid A.; Johnson, Howard L.

In: Journal of Medicinal Chemistry, Vol. 23, No. 9, 01.01.1980, p. 985-990.

Research output: Contribution to journalArticle

Reifenrath, William G. ; Roche, Edward B. ; Al-Turk, Walid A. ; Johnson, Howard L. / Synthesis and Biological Activity of Fluoroalkylamine Derivatives of Narcotic Analgesics. In: Journal of Medicinal Chemistry. 1980 ; Vol. 23, No. 9. pp. 985-990.
@article{e0ea7edf81b94c15b271852596dd6d23,
title = "Synthesis and Biological Activity of Fluoroalkylamine Derivatives of Narcotic Analgesics",
abstract = "N-Ethyl-, N-(2-fluoroethyl)-, N-(2, 2-difluoroethyl)-, and N-(2, 2, 2-trifluoroethyl)-substituted normeperidine (lb-e) and normetazocine (2b-e) derivatives were prepared. The analgesic activities of the compounds were determined in mice. Opiate receptor binding studies, in the presence and absence of sodium ion, were carried out. The antagonist activities of normetazocine derivatives were studied in monkeys. These were further examined in the isolated guinea pig ileum for relative agonist activity. The pKt values were measured; in vivo agonist activity was lost with weakly basic derivatives. For the normetazocine derivatives, opiate receptor binding data were consistent with guinea pig ileum agonist potency and mouse vas deferens antagonist potency but not with in vivo data. Opiate receptor binding was reduced for the less basic normetazocine derivatives. In the normeperidine series, there was no apparent direct relationship between pKt and opiate receptor binding. However, a relationship involving the hydrophobic character of the N-substituent is discussed. The N-(2-fluoroethyl) derivatives in both series were found to cause convulsions in rats at doses of 40-45 mg/kg ip. Elevated serum citrate levels were found in these rats, implicating in vivo oxidative deamination of the N-(fluoroalkyl) substituent to fluoroacetate.",
author = "Reifenrath, {William G.} and Roche, {Edward B.} and Al-Turk, {Walid A.} and Johnson, {Howard L.}",
year = "1980",
month = "1",
day = "1",
doi = "10.1021/jm00183a005",
language = "English (US)",
volume = "23",
pages = "985--990",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "9",

}

TY - JOUR

T1 - Synthesis and Biological Activity of Fluoroalkylamine Derivatives of Narcotic Analgesics

AU - Reifenrath, William G.

AU - Roche, Edward B.

AU - Al-Turk, Walid A.

AU - Johnson, Howard L.

PY - 1980/1/1

Y1 - 1980/1/1

N2 - N-Ethyl-, N-(2-fluoroethyl)-, N-(2, 2-difluoroethyl)-, and N-(2, 2, 2-trifluoroethyl)-substituted normeperidine (lb-e) and normetazocine (2b-e) derivatives were prepared. The analgesic activities of the compounds were determined in mice. Opiate receptor binding studies, in the presence and absence of sodium ion, were carried out. The antagonist activities of normetazocine derivatives were studied in monkeys. These were further examined in the isolated guinea pig ileum for relative agonist activity. The pKt values were measured; in vivo agonist activity was lost with weakly basic derivatives. For the normetazocine derivatives, opiate receptor binding data were consistent with guinea pig ileum agonist potency and mouse vas deferens antagonist potency but not with in vivo data. Opiate receptor binding was reduced for the less basic normetazocine derivatives. In the normeperidine series, there was no apparent direct relationship between pKt and opiate receptor binding. However, a relationship involving the hydrophobic character of the N-substituent is discussed. The N-(2-fluoroethyl) derivatives in both series were found to cause convulsions in rats at doses of 40-45 mg/kg ip. Elevated serum citrate levels were found in these rats, implicating in vivo oxidative deamination of the N-(fluoroalkyl) substituent to fluoroacetate.

AB - N-Ethyl-, N-(2-fluoroethyl)-, N-(2, 2-difluoroethyl)-, and N-(2, 2, 2-trifluoroethyl)-substituted normeperidine (lb-e) and normetazocine (2b-e) derivatives were prepared. The analgesic activities of the compounds were determined in mice. Opiate receptor binding studies, in the presence and absence of sodium ion, were carried out. The antagonist activities of normetazocine derivatives were studied in monkeys. These were further examined in the isolated guinea pig ileum for relative agonist activity. The pKt values were measured; in vivo agonist activity was lost with weakly basic derivatives. For the normetazocine derivatives, opiate receptor binding data were consistent with guinea pig ileum agonist potency and mouse vas deferens antagonist potency but not with in vivo data. Opiate receptor binding was reduced for the less basic normetazocine derivatives. In the normeperidine series, there was no apparent direct relationship between pKt and opiate receptor binding. However, a relationship involving the hydrophobic character of the N-substituent is discussed. The N-(2-fluoroethyl) derivatives in both series were found to cause convulsions in rats at doses of 40-45 mg/kg ip. Elevated serum citrate levels were found in these rats, implicating in vivo oxidative deamination of the N-(fluoroalkyl) substituent to fluoroacetate.

UR - http://www.scopus.com/inward/record.url?scp=0019168404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019168404&partnerID=8YFLogxK

U2 - 10.1021/jm00183a005

DO - 10.1021/jm00183a005

M3 - Article

C2 - 6106064

AN - SCOPUS:0019168404

VL - 23

SP - 985

EP - 990

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 9

ER -